Genomic sequencing remains a relatively early stage market, and expanding sequencing indications, including the nascent liquid biopsy applications that would use its sequencers, create large growth ...

Carl Icahn’s Icahn Capital disclosed in an SEC filing its holdings as of December 31, 2024. The fund increased its stakes in two holdings, ...

Carl Icahn (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2024, providing insights into his inve ...

Billionaire activist investor and ‘corporate raider’ Carl Icahn is lining up a proxy battle at Illumina in the wake of its troubled $7.1 billion takeover of blood-based cancer diagnostics ...

Billionaire activist investor Carl Icahn's Icahn Enterprises reduced stakes in Southwest Gas (NYSE:SWX), Illumina (ILMN), and Centuri Holdings (CTRI), according to the fund's latest 13F filing. Icahn ...

Illumina has bitten back against the attempt by billionaire activist investor Carl Icahn to introduce three members to its board, saying that they lack “experience in and knowledge of” its ...

Carl Icahn plans to nominate three people to the board of the San Diego-based company, according to a letter Mr. Icahn plans to send to Illumina shareholders on Monday. Icahn says in the letter that ...

Dana has entered an agreement to add two new board members picked by Carl Icahn’s company, one of whom is his son Brett. Brett Icahn and Christian Garcia are set to join the board of the ...